T1	Participants 174 187	some patients
T2	Participants 323 341	patients with acne
T3	Participants 713 780	female subjects, 15 to 49 years of age with moderate acne vulgaris,
T4	Participants 899 907	subjects
T5	Participants 1257 1282	subject's self-assessment
T6	Participants 1369 1417	160 subjects in whom efficacy could be evaluated
T7	Participants 1494 1511	the placebo group
T8	Participants 2406 2459	in women with no known contraindication to OC therapy
